• Gene fusion; HGNC; HGNC:1582; CCND1 + HGNC; HGNC:5477; IGH; Name(s)=IGH-CCND1 (PubMed=24611650).
  

PubMed=24611650; DOI=10.3109/10428194.2014.901511; PMCID=PMC5779854
Pham L.V., Vang M.T., Tamayo A.T., Lu G., Challagundla P., Jorgensen J.L., Rollo A.A., Ou Z.-S., Zhang L., Wang M., Ford R.J. Jr.
Involvement of tumor-associated macrophage activation in vitro during development of a novel mantle cell lymphoma cell line, PF-1, derived from a typical patient with relapsed disease.
Leuk. Lymphoma 56:186-193(2015)

PubMed=29666304; DOI=10.1158/1078-0432.CCR-17-3004
Pham L.V., Huang S.-J., Zhang H., Zhang J., Bell T., Zhou S.-H., Pogue E., Ding Z.-Y., Lam L., Westin J., Davis R.E., Young K.H., Medeiros L.J., Ford R.J. Jr., Nomie K., Zhang L., Wang M.
Strategic therapeutic targeting to overcome venetoclax resistance in aggressive B-cell lymphomas.
Clin. Cancer Res. 24:3967-3980(2018)

PubMed=30209121; DOI=10.1182/blood-2018-03-841015; PMCID=PMC6634963
Li L., Zhang J., Chen J., Xu-Monette Z.-J.Y.-D., Miao Y., Xiao M., Young K.H., Wang S., Medeiros L.J., Wang M., Ford R.J. Jr., Pham L.V.
B-cell receptor-mediated NFATc1 activation induces IL-10/STAT3/PD-L1 signaling in diffuse large B-cell lymphoma.
Blood 132:1805-1817(2018)